Search Results
You are looking at 1 - 7 of 7 items for
- Author: W. A. D. ANDERSON x
- Refine by access: All content x
Search for other papers by S. A. GUNN in
Google Scholar
PubMed
Search for other papers by THELMA C. GOULD in
Google Scholar
PubMed
Search for other papers by W. A. D. ANDERSON in
Google Scholar
PubMed
SUMMARY
Eleven days following hypophysectomy the capacity of the rat testis to take up administered 65Zn is markedly depressed below values noted in intact controls, even though microscopically there is only a slight diminution in the number of germinal epithelial and interstitial elements. Interstitial cell-stimulating hormone (ICSH) in doses of 5 μg./day administered from the 5th to the 10th day after operation completely prevented the fall in total 65Zn uptake of the testis following removal of the pituitary. Follicle stimulating hormone (FSH) was less effective than ICSH in this regard. The possibility of the FSH effect being due to contamination with ICSH is considered. Growth hormone and prolactin in doses of 200 μg./day administered from the 5th to 10th day after operation were ineffective in preventing the fall in 65Zn uptake of the testis following hypophysectomy.
Search for other papers by P. A. Cossum in
Google Scholar
PubMed
Search for other papers by D. E. Hill in
Google Scholar
PubMed
Search for other papers by J. R. Bailey in
Google Scholar
PubMed
Search for other papers by J. H. Anderson in
Google Scholar
PubMed
Search for other papers by W. Slikker Jr in
Google Scholar
PubMed
ABSTRACT
A synthetic version of the human relaxin encoded by the human gene 2 (hRlx-2) was administered to pregnant rhesus monkeys (Macaca mulatta) on gestational days 141–158. Monkeys (three per group) received doses of 100 μg/kg or 2000 μg/kg as a continuous i.v. infusion over 2 h into a radial vein. One monkey in the low-dose group received, along with the unlabelled hRlx-2, 25·5 μCi/kg of the test material internally labelled with [35S]cysteine. Immunoreactive hRlx-2, as measured by enzyme-linked immunosorbent assay, appeared in all fetuses within 30 min (the first sampling time) of beginning the infusions. Peak fetal plasma levels of hRlx-2 were only 0·8–1·5% of the maternal values. Only 8–15% of the fetal serum radioactivity was hRlx-2. Radioactivity from maternal urine pooled over the 4-h experiment did not elute at the volume corresponding to hRlx-2, but near the column volume.
Journal of Endocrinology (1991) 130, 339–345
Search for other papers by W. R. Robertson in
Google Scholar
PubMed
Search for other papers by B. Davison in
Google Scholar
PubMed
Search for other papers by D. C. Anderson in
Google Scholar
PubMed
Search for other papers by J. Frost in
Google Scholar
PubMed
Search for other papers by A. Lambert in
Google Scholar
PubMed
ABSTRACT
We have studied cortisol and androstenedione secretion by dispersed cells of the outer zona fasciculata (ZF) plus zona glomerulosa, and the inner zona reticularis (ZR) plus medulla of the guinea-pig adrenal. The ZF and ZR were microdissected apart, the cells dispersed and incubated (200 000 cells/ml) for 90 min in the presence of adrenocorticotrophin (ACTH; 500 ng/l), dibutyryl cyclic AMP (dbcAMP; 1 mmol/l), pregnenolone, 17-hydroxypregnenolone, 17-hydroxyprogesterone, 11-deoxycortisol and 21-deoxycortisol. The steroid concentrations were 5–25 μmol/l. Cortisol secretion was assayed by radioimmunoassay. There was no detectable cortisol secretion ( < 50 nmol/l) from the ZR in the controls (no additive) or after dbcAMP stimulation. Adrenocorticotrophin-stimulated cortisol secretion was also low (range < 50–340 nmol/l). In contrast the ZF secreted 177–379 (control), 828–2052 (dbcAMP) and 2863–9735 (ACTH) nmol cortisol/l. There was no detectable (i.e. < 2 nmol/l) cAMP production by ZR or ZF either basally (no ACTH) or after ACTH stimulation (500 ng/l). Challenge of the ZR cells with each cortisol precursor steroid (5 μmol/l) increased (P < 0·05) cortisol secretion over that seen with the corresponding basal and ACTH-stimulated controls. Thus pregnenolone, 17-hydroxypregnenolone, 17-hydroxyprogesterone, 11-deoxycortisol and 21-deoxycortisol (converted directly to cortisol by 21-hydroxylase) gave rise to (mean ± s.d., n = 4) 406 ± 86, 680 ± 180, 1307 ± 111, 1141 ± 234 and 3160 ± 419 nmol cortisol/l respectively. The corresponding figures for the ZF prepared from the same adrenal cortex were 3919 ± 309, 4122 ± 97, 5766 ± 615, 5035 ± 260 and 6954 ± 755 nmol cortisol/l. With pregnenolone (25 μmol/l), cortisol secretion increased to 7847 ± 1424 (ZR) and 12880 ± 982 nmol/l (ZF), a ZR:ZF ratio of 0·6 compared with 0·1 for pregnenolone at 5 μmol/l. Androstenedione was secreted in the basal state by both ZF and ZR in similar quantities, i.e. 3·7 ± 0·3 and 3·7 ± 0·4 nmol/l (n = 9 and 14 respectively). Both cell types were ACTH sensitive, with androstenedione secretion increasing to 28 ± 4·8 (ZF) and 12·5 ± 0·9 (ZR) nmol/l.
There was a direct correlation (r = 0·924, P < 0·05) between total adrenal weight and body weight, between the percentage ZR in the cortex and adrenal weight (r = 0·96, P < 0·05) and between the percentage ZR and body weight (r = 0·981, P< 0·05). In a mature animal (800–1000 g) the ZR may occupy > 66% of the adrenal cortex. The mean diameters of cells from the ZF and ZR were 21 and 25 μm respectively.
J. Endocr. (1986) 109, 399–404
Search for other papers by A. D. CARE in
Google Scholar
PubMed
Search for other papers by L. L. ANDERSON in
Google Scholar
PubMed
Search for other papers by C. W. COOPER in
Google Scholar
PubMed
Search for other papers by S. L. OXENREIDER in
Google Scholar
PubMed
Search for other papers by M. PHILLIPPO in
Google Scholar
PubMed
The surgically isolated thyroid gland in the pig has been shown to secrete thyrocalcitonin (TC) when perfused with an artificial medium, hypercalcaemic with respect to ionized calcium concentration (Care & Gitelman, 1968). Therefore, hypophysial hormones must not be essential for the release of at least some TC stimulated by hypercalcaemia. The present work was designed to evaluate quantitatively the effect of previous hypophysectomy on the rate of secretion of TC in response to a given degree of hypercalcaemia.
In preliminary experiments, a pair of litter-mate male piglets, 19 days old, was selected and one was hypophysectomized by an adaptation of the method of Liggins, Kennedy & Holm (1967). At autopsy, hypophysectomy was confirmed by visual examination of the sella turcica. Nine days after operation, the thyroid was isolated in situ and perfused with hypercalcaemic blood (6·7 m-equiv.Ca/1.) for 2 hr. according to the method of Care (1965). The thyroid of
Search for other papers by J. C. MARSHALL in
Google Scholar
PubMed
Search for other papers by D. C. ANDERSON in
Google Scholar
PubMed
Search for other papers by C. W. BURKE in
Google Scholar
PubMed
Search for other papers by A. GALVAO-TELES in
Google Scholar
PubMed
Search for other papers by T. RUSSELL FRASER in
Google Scholar
PubMed
SUMMARY
The effects of clomiphene citrate were studied in nine normal men, in three patients with partial panhypopituitarism, and in four patients with isolated gonadotrophin deficiency. The administration of this drug to the normal subjects in a dosage of 3 mg/kg/day for 10 days resulted in a mean rise in serum luteinizing hormone (LH) of 107%, in plasma 17β-hydroxyandrogens (17-OHA) of 114%, and in plasma total cortisol of 86%. The rise of testosterone concentration in normal subjects was associated with a doubling of the non-protein bound fraction, and also with increased binding of testosterone to sex hormone-binding globulin (SHBG). In contrast, plasma non-protein bound and urinary unconjugated cortisol remained unchanged. The percentage of plasma cortisol not bound to protein fell, indicating that the rise in total plasma cortisol was secondary to increased protein binding. This was confirmed by finding increased binding of both cortisol and testosterone to their specific binding globulins at 1 °C, due apparently to increased concentrations of SHBG and corticosteroid-binding globulin after clomiphene administration. All the responses to clomiphene were prevented by simultaneous administration of fluoxymesterone in two normal subjects.
All the hypopituitary patients showed no rise of LH, 17-OHA or cortisol. The hypogonadotrophic patients, however, showed a normal total cortisol rise.
It is suggested that clomiphene has two actions. First, it interferes with the hypothalamic feed-back mechanisms for testosterone, resulting in increased LH secretion, and secondly it has an oestrogen-like effect in stimulating production of steroid-binding globulins.
Search for other papers by W. WATSON BUCHANAN in
Google Scholar
PubMed
Search for other papers by D. A. KOUTRAS in
Google Scholar
PubMed
Search for other papers by J. CROOKS in
Google Scholar
PubMed
Search for other papers by W. D. ALEXANDER in
Google Scholar
PubMed
Search for other papers by W. BRASS in
Google Scholar
PubMed
Search for other papers by J. R. ANDERSON in
Google Scholar
PubMed
Search for other papers by R. B. GOUDIE in
Google Scholar
PubMed
Search for other papers by K. G. GRAY in
Google Scholar
PubMed
SUMMARY
The significance of a positive thyroid complement-fixation (c.f.) test in thyrotoxicosis has been investigated by studying the correlation between various features of the disease in 468 patients. A significant correlation was found between the positivity of the c.f. test and (1) the degree of lymphocytic infiltration in the gland; (2) incidence of postoperative hypothyroidism; (3) size of the goitre; (4) previous treatment with radioiodine, and (5) a family history of thyroid disease. No correlation was found between the results of the test and the incidence of reactions to antithyroid drugs. The results suggest that thyrotoxic patients with positive c.f. tests should be treated initially with antithyroid drugs unless there is a definite indication for surgery.
Search for other papers by M. D. MITCHELL in
Google Scholar
PubMed
Search for other papers by J. G. BIBBY in
Google Scholar
PubMed
Search for other papers by B. R. HICKS in
Google Scholar
PubMed
Search for other papers by C. W. G. REDMAN in
Google Scholar
PubMed
Search for other papers by ANNE B. M. ANDERSON in
Google Scholar
PubMed
Search for other papers by A. C. TURNBULL in
Google Scholar
PubMed
The concentration of thromboxane B2 has been measured in the plasma of women during late pregnancy, during term and pre-term labour, in women with pre-eclampsia and in umbilical cord arterial and venous plasma. In addition, the rates of production of thromboxane B2 in vitro were determined for placental tissues obtained after spontaneous vaginal delivery or elective Caesarean section. The results obtained indicate significant differences during parturition between the sources and controlling mechanisms of thromboxane and prostaglandin production.
